Melatonin-Mepha 2 mg, Retardtabletten - 100 Swissmedic Key 68681002 Registration Holder Mepha Pharma AG Name Melatonin-Mepha 2 mg, Retardtabletten Date of registration 11.08.2022 Introduction of Sequence 11.08.2022 ATC-Classification Melatonin (N05CH01) Revision date WHO WHO-DDD Valid until 10.08.2027 Index Therapeuticus (BSV) Show package size 100 Index Therapeuticus (Swissmedic) 01.03.10. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680686810020 Medication Code Synthetika Pharmacode Disponibility
Composition melatoninum 2 mg, ammonio methacrylatis copolymerum B, calcii hydrogenophosphas dihydricus, talcum, lactosum monohydricum 80 mg, magnesii stearas, silica colloidalis anhydrica, pro compresso obducto. Packungsbestandteile Galenic Form Delayed release tablets Active Agent Dose Melatoninum 2 mg
Inactive agents Dose Ammonio Methacrylatis Copolymerum B Calcium Hydrogen Phosphate Dihydrate Lactose Monohydrate 80 mg Magnesii Stearas Pro Compresso Obducto Silica Colloidalis Anhydrica Talcum
Source Data was imported : 02.09.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
